Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs HESTER BIOSCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER HESTER BIOSCIENCES PFIZER/
HESTER BIOSCIENCES
 
P/E (TTM) x 38.2 73.6 51.9% View Chart
P/BV x 6.0 4.2 141.6% View Chart
Dividend Yield % 1.7 0.6 289.9%  

Financials

 PFIZER   HESTER BIOSCIENCES
EQUITY SHARE DATA
    PFIZER
Mar-23
HESTER BIOSCIENCES
Mar-23
PFIZER/
HESTER BIOSCIENCES
5-Yr Chart
Click to enlarge
High Rs4,6622,852 163.5%   
Low Rs3,4071,416 240.6%   
Sales per share (Unadj.) Rs530.0312.7 169.5%  
Earnings per share (Unadj.) Rs136.432.9 414.0%  
Cash flow per share (Unadj.) Rs159.457.3 278.4%  
Dividends per share (Unadj.) Rs70.008.00 875.0%  
Avg Dividend yield %1.70.4 462.8%  
Book value per share (Unadj.) Rs701.0328.7 213.3%  
Shares outstanding (eoy) m45.758.51 537.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.66.8 111.6%   
Avg P/E ratio x29.664.7 45.7%  
P/CF ratio (eoy) x25.337.3 67.9%  
Price / Book Value ratio x5.86.5 88.7%  
Dividend payout %51.324.3 211.4%   
Avg Mkt Cap Rs m184,57618,152 1,016.8%   
No. of employees `000NANA-   
Total wages/salary Rs m3,317560 592.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,2482,661 911.3%  
Other income Rs m1,011154 658.0%   
Total revenues Rs m25,2582,814 897.4%   
Gross profit Rs m8,420548 1,536.1%  
Depreciation Rs m1,055207 509.8%   
Interest Rs m13593 144.6%   
Profit before tax Rs m8,240402 2,052.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,001121 1,651.0%   
Profit after tax Rs m6,239280 2,225.5%  
Gross profit margin %34.720.6 168.6%  
Effective tax rate %24.330.2 80.5%   
Net profit margin %25.710.5 244.2%  
BALANCE SHEET DATA
Current assets Rs m24,9332,276 1,095.5%   
Current liabilities Rs m6,5741,487 442.1%   
Net working cap to sales %75.729.7 255.4%  
Current ratio x3.81.5 247.8%  
Inventory Days Days9347 198.0%  
Debtors Days Days2109 2.1%  
Net fixed assets Rs m13,7804,424 311.5%   
Share capital Rs m45885 537.8%   
"Free" reserves Rs m31,6162,712 1,165.7%   
Net worth Rs m32,0732,797 1,146.6%   
Long term debt Rs m01,849 0.0%   
Total assets Rs m39,0316,700 582.6%  
Interest coverage x62.15.3 1,170.4%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x0.60.4 156.4%   
Return on assets %16.35.6 292.9%  
Return on equity %19.510.0 194.1%  
Return on capital %26.110.6 245.2%  
Exports to sales %2.811.6 24.4%   
Imports to sales %00-   
Exports (fob) Rs m688309 222.7%   
Imports (cif) Rs m8NA-   
Fx inflow Rs m688309 222.7%   
Fx outflow Rs m839 21.7%   
Net fx Rs m679270 251.6%   
CASH FLOW
From Operations Rs m3,557236 1,507.4%  
From Investments Rs m-361-770 46.8%  
From Financial Activity Rs m-3,458418 -828.1%  
Net Cashflow Rs m-262-116 225.6%  

Share Holding

Indian Promoters % 0.0 44.3 -  
Foreign collaborators % 63.9 9.5 676.4%  
Indian inst/Mut Fund % 18.2 0.4 4,227.9%  
FIIs % 3.0 0.4 704.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 46.3 78.0%  
Shareholders   112,456 13,450 836.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Pfizer vs HESTER PHARM

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs HESTER PHARM Share Price Performance

Period Pfizer HESTER PHARM S&P BSE HEALTHCARE
1-Day -4.80% 1.12% 1.18%
1-Month -8.24% -1.37% -0.75%
1-Year 21.78% -14.68% 61.82%
3-Year CAGR -2.07% -9.87% 18.16%
5-Year CAGR 4.95% -2.54% 19.79%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the HESTER PHARM share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of HESTER PHARM the stake stands at 53.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of HESTER PHARM.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.

HESTER PHARM paid Rs 8.0, and its dividend payout ratio stood at 24.3%.

You may visit here to review the dividend history of Pfizer, and the dividend history of HESTER PHARM.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.